Nutriproteomics and Proteogenomics: Cultivating Two Novel Hybrid Fields of Personalized Medicine with Added Societal Value.
作者信息
Ozdemir Vural, Armengaud Jean, Dubé Laurette, Aziz Ramy Karam, Knoppers Bartha M
机构信息
Centre of Genomics and Policy, Department of Human Genetics, Faculty of Medicine, McGill University, Montreal, QC, Canada.
出版信息
Curr Pharmacogenomics Person Med. 2010 Dec 1;8(4):240-244. doi: 10.2174/187569210793368230.
Abstract
摘要
相似文献
1
Nutriproteomics and Proteogenomics: Cultivating Two Novel Hybrid Fields of Personalized Medicine with Added Societal Value.营养蛋白质组学和蛋白质基因组学：培育两个具有附加社会价值的个性化医学新型交叉领域。
Curr Pharmacogenomics Person Med. 2010 Dec 1;8(4):240-244. doi: 10.2174/187569210793368230.
2
Situating Nutri-Ethics at the Junction of Nutrigenomics and Nutriproteomics in Postgenomics Medicine.在后基因组医学中，将营养伦理学置于营养基因组学与营养蛋白质组学的交叉点上。
Curr Pharmacogenomics Person Med. 2013 Jun;11(2):162-166. doi: 10.2174/1875692111311020008.
3
Clinical potential of mass spectrometry-based proteogenomics.基于质谱的蛋白质基因组学的临床潜力。
Nat Rev Clin Oncol. 2019 Apr;16(4):256-268. doi: 10.1038/s41571-018-0135-7.
4
Proteogenomics: Key Driver for Clinical Discovery and Personalized Medicine.蛋白质基因组学：临床发现与个性化医疗的关键驱动力
Adv Exp Med Biol. 2016;926:21-47. doi: 10.1007/978-3-319-42316-6_3.
5
Phenotyping Tumor Heterogeneity through Proteogenomics: Study Models and Challenges.通过蛋白质基因组学进行肿瘤异质性表型分析：研究模型与挑战。
Int J Mol Sci. 2024 Aug 14;25(16):8830. doi: 10.3390/ijms25168830.
6
Proteogenomics in Nephrology: A New Frontier in Nephrological Research.肾脏病学中的蛋白质基因组学：肾脏病学研究的新前沿。
Curr Issues Mol Biol. 2024 May 11;46(5):4595-4608. doi: 10.3390/cimb46050279.
7
Clinical implications of recent advances in proteogenomics.蛋白质基因组学最新进展的临床意义
Expert Rev Proteomics. 2016;13(2):185-99. doi: 10.1586/14789450.2016.1132169. Epub 2016 Jan 13.
8
Onco-proteogenomics: Multi-omics level data integration for accurate phenotype prediction.肿瘤-基因组学：多组学水平数据的整合以实现准确的表型预测。
Crit Rev Clin Lab Sci. 2017 Sep;54(6):414-432. doi: 10.1080/10408363.2017.1384446. Epub 2017 Oct 12.
9
Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis.个性化单细胞蛋白质基因组学区分急性髓系白血病与非恶性克隆性造血
Blood Cancer Discov. 2021 Jul;2(4):319-325. doi: 10.1158/2643-3230.BCD-21-0046. Epub 2021 May 25.
10
Nutrigenomics and Breast Cancer: State-of-Art, Future Perspectives and Insights for Prevention.营养基因组学与乳腺癌：现状、未来展望及预防见解。
Nutrients. 2020 Feb 18;12(2):512. doi: 10.3390/nu12020512.
引用本文的文献
1
Situating Nutri-Ethics at the Junction of Nutrigenomics and Nutriproteomics in Postgenomics Medicine.在后基因组医学中，将营养伦理学置于营养基因组学与营养蛋白质组学的交叉点上。
Curr Pharmacogenomics Person Med. 2013 Jun;11(2):162-166. doi: 10.2174/1875692111311020008.
2
Personalized Medicine in the Age of Pharmacoproteomics: A Close up on India and Need for Social Science Engagement for Responsible Innovation in Post-Proteomic Biology.药物蛋白质组学时代的个性化医疗：聚焦印度以及后蛋白质组生物学中负责任创新的社会科学参与需求
Curr Pharmacogenomics Person Med. 2011 Mar 1;9(1):67-75. doi: 10.2174/187569211794728850.
3
Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine.《2020年亚太地区健康与无国界基因组学：科学与社会伙伴关系促进全球个性化医疗的知识共同生产》
Curr Pharmacogenomics Person Med. 2011 Mar 1;9(1):1-5. doi: 10.2174/187569211794728841.
本文引用的文献
1
The call of the human proteome.人类蛋白质组的召唤。
Nat Methods. 2010 Sep;7(9):661. doi: 10.1038/nmeth0910-661.
2
Mass spectrometry in high-throughput proteomics: ready for the big time.高通量蛋白质组学中的质谱：准备迎接大时代。
Nat Methods. 2010 Sep;7(9):681-5. doi: 10.1038/nmeth0910-681.
3
A vision for 21st century U.S. Policy to support sustainable advancement of scientific discovery and technological innovation.21世纪美国支持科学发现和技术创新可持续发展的政策愿景。
OMICS. 2010 Aug;14(4):333-5. doi: 10.1089/omi.2010.0068.
4
Is a gene-centric human proteome project the best way for proteomics to serve biology?以基因为中心的人类蛋白质组计划是蛋白质组学为生物学服务的最佳途径吗？
Proteomics. 2010 Sep;10(17):3067-72. doi: 10.1002/pmic.201000220.
5
Personalized Medicine Beyond Genomics: New Technologies, Global Health Diplomacy and Anticipatory Governance.超越基因组学的个性化医疗：新技术、全球卫生外交与前瞻性治理
Curr Pharmacogenomics Person Med. 2009 Dec;7(4):225-230. doi: 10.2174/187569209790112283.
6
Personalizing Stem Cell Research and Therapy: The Arduous Road Ahead or Missed Opportunity?个性化干细胞研究与治疗：前方道路崎岖还是错失良机？
Curr Pharmacogenomics Person Med. 2010 Mar 1;8(1):25-36. doi: 10.2174/1875692111008010025.
7
Global health diplomacy for obesity prevention: lessons from tobacco control.全球肥胖预防卫生外交：借鉴烟草控制经验。
J Public Health Policy. 2010 Jul;31(2):244-55. doi: 10.1057/jphp.2010.4.
8
A gene-centric human proteome project: HUPO--the Human Proteome organization.以基因为中心的人类蛋白质组计划：人类蛋白质组组织（HUPO）
Mol Cell Proteomics. 2010 Feb;9(2):427-9. doi: 10.1074/mcp.H900001-MCP200.
9
Proteogenomics and systems biology: quest for the ultimate missing parts.蛋白质基因组学与系统生物学：探寻最终缺失的环节
Expert Rev Proteomics. 2010 Feb;7(1):65-77. doi: 10.1586/epr.09.104.
10
A hundred-year-old insight into the gut microbiome!百年洞察肠道微生物组！
Gut Pathog. 2009 Dec 7;1(1):21. doi: 10.1186/1757-4749-1-21.
Zotero 插件